Wakako Furuyama

This study evaluates the protective efficacy of low-dose VSV-EBOV vaccines in nonhuman primates, finding reduced protection with a Makona GP vaccine compared to a Kikwit GP vaccine.

This paper demonstrates a viral vaccine strategy using BCG-induced Th cells to enhance antibody responses against Ebola virus, providing protection in a mouse model.

The paper identifies distinct PE2 subcategories in paramyxoviruses and shows that four U-containing hexamer repeats are critical for filovirus genome replication.